Analogue - A complete drug design suite

Growdea Technologies is an Indian biotechnology startup founded in 2018 that specializes in in-silico drug discovery, computational biology, and bioinformatics. The company leverages artificial intelligence, machine learning, and physics-based simulations to develop its flagship platform, Analogue. This technology enables researchers to conduct virtual screening, molecular modeling, and binding affinity predictions. By integrating these computational modules, the platform streamlines the early-stage drug design process, allowing for the digital analysis of millions of molecules before moving to traditional laboratory validation.

This approach is designed to help small biotech companies, academic labs, and pharmaceutical firms significantly reduce the time and costs associated with drug development. By identifying promising drug candidates digitally, Growdea aims to decrease discovery timelines from years to months and lower associated expenses. The company provides these services to support drug efficacy prediction, vaccine development, and antibody engineering, helping clients make data-driven decisions throughout the drug development pipeline. The startup is headquartered in India with operations expanding into international markets.